Stephen Kish

Stephen Kish is a physician whose research helps turn an abstract fear about methamphetamine into a specific, qualified possibility: that some drug-related changes in the brain may recover. In David Sheff’s account, Kish’s postmortem study finds profound depletion of dopamine but also normal levels of a marker associated with dopamine nerve terminals. That combination does not promise recovery, but it gives the question of whether Nic Sheff’s brain can heal a scientific basis for hope.

Identity and Research Context

Kish is identified as a doctor at the medical center of the University of Toronto. His study preceded Edythe London’s brain-imaging research by three years and approached the problem through postmortem brain tissue rather than scans of living participants. The people whose brains he examined had either died of a methamphetamine overdose or had a high level of the drug in their systems when they died in an accident or were killed by gunfire. The account does not suggest that Kish studied Nic Sheff; his findings enter the family narrative as research relevant to Nic’s condition, not as a diagnosis of him.

The contrast between visible and microscopic damage gives Kish’s work particular force in the book. The brains of people with alcohol dependence had long been presented in health-class images as visibly shrunken and eroded beside healthy-looking brains. The methamphetamine users’ brains in Kish’s study showed no comparable damage to the naked eye. The absence of an obvious external change, however, did not mean the absence of injury: at the microscopic level, researchers observed nerve endings that appeared singed. The account thus moves from an image of damage that can be seen to evidence that requires laboratory analysis.

Method and Findings

Kish’s investigation proceeded from the visible organ to its chemistry. He used biochemical probes and analyzed twenty-milligram samples of brain tissue, measuring specific neurotransmitters against levels in normal brains. The findings distinguished degrees of change: serotonin and other neurotransmitters were diminished modestly, while dopamine was reduced by 90 to 95 percent. Dopamine transporters, associated with the release of the chemical, were depleted as well. The scale of the dopamine loss gave the concern about methamphetamine’s effect on the brain a precise, unsettling measure.

Kish’s results formed part of a wider body of research. Other scientists found similar depletions in the brains of methamphetamine-addicted monkeys, baboons, mice, and rats. Taken together, those findings supported the conclusion that methamphetamine is neurotoxic and can physically alter the brain more substantially than cocaine and most other drugs. The book does not attribute those animal studies to Kish himself; instead, it places his human brain research alongside them to show how evidence from different studies reinforced the concern about neurological damage.

A second question was more consequential than the amount of dopamine lost: whether the nerve terminals that release it had been permanently destroyed. Kish examined vesicular monoamine transporter, or V-MAT2, as a marker relevant to that distinction. The account explains the significance by comparison with Parkinson’s disease, in which permanent loss of dopamine neurons is associated with extremely low V-MAT2 levels. If Kish had found the marker depleted in the methamphetamine users’ brains, that would have suggested a loss of nerve terminals and made irreversible damage more likely. Instead, he found normal levels. This result did not erase the evidence of severe depletion, but it changed what that depletion might mean for the possibility of recovery.

Recovery and Its Limits

Kish’s normal V-MAT2 finding is presented as surprising and hopeful. The research, including subsequent work described in the book, indicates that damaged nerve endings may grow back, though the process may take as long as two years. The time span matters: recovery is not depicted as immediate, and the evidence remains qualified. The book’s conclusion is that people addicted to methamphetamine can probably recover, not that every effect is known to reverse or that the outcome is guaranteed.

For David Sheff, this scientific qualification carries personal weight. The research bears directly on his fear that Nic Sheff might survive addiction without returning to his former mental condition. The prospect that the brain can recover is conditional on staying off the drug; the book emphasizes that condition rather than treating the finding as an automatic cure. Repeated in the account is the tension between hope and uncertainty: recovery may be possible, but abstinence and time are essential to the possibility described.

Narrative Significance

Kish’s importance in the narrative lies in the narrowness and consequence of his finding. His study cannot settle the larger questions surrounding addiction, choice, and responsibility that trouble David Sheff. Elsewhere, family members and treatment professionals dispute how to understand addiction: as a disease involving compulsion, as a condition for which a person remains responsible, or as both. Kish’s research addresses a different question. It offers evidence about physical changes in the brain and the possibility that some of them may not be permanent; it does not, by itself, resolve who is responsible for treatment or what recovery requires.

That distinction helps the book keep hope from becoming certainty. A finding about possible regrowth gives David Sheff a reason to imagine that Nic’s future is not fixed by the damage associated with methamphetamine use. Yet the two-year horizon and the requirement that Nic stay off the drug keep that hope grounded in risk and duration. Kish appears not as a family confidant or a character in Nic’s treatment, but as a researcher whose measured result alters the emotional meaning of the evidence: severe brain change and the possibility of recovery can coexist.